RPL9 and metabolic syndrome: Similarly, the mean methylation for the promoter of RPL9 was significantly associated with MetS when controlling for age, gender, and smoking status [the adjusted odds ratio: 0.56, 95% confidence interval: 0.38–0.82], p < 0.01.